Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
Spotlight on Asia-Pacific: Practice Beyond Borders
Hiraji Iwata, MD, PhD
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
The Future of Oral SERDs: Combination Strategies
Spotlight on Latin America: Closing the Gap
Cynthia Villarreal-Garza, MD, DSc
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
Routes Reconsidered: A Case-Based Debate in SERD Selection
Spotlight on Europe: Adapting the Evidence
Real-World Cases in Pediatric Low-Grade Glioma: Exploring Targeted Therapies
Alexandria May, PharmD, BCPS
Angela Waanders, MD, MPH, MS
Ashley S. Margol, MD, MS
Examining the Treatment Paradigm for Paroxysmal Nocturnal Hemoglobinuria
Charles Turck, PharmD, BCPS, BCCCP
Brian Mulherin, MD
Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Conquering the Burden & Impacts of PNH
Hana Safah, MD
Timothy Kubal, MD
Understanding the Role of the Alternate Complement Pathway in PNH
Jennifer Caudle, DO, FACOFP
Catherine Broome, MD
Recognizing the Burden of Paroxysmal Nocturnal Hemoglobinuria
Brian P. McDonough, MD, FAAFP
Improving PNH Patient Outcomes
David Dingli, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.